Accutane, a brand name for isotretinoin, is available as a generic medication. Isotretinoin is used to treat severe acne that has not responded to other treatments [1].
When does Accutane's patent expire?
The original patents for Accutane have long expired, allowing for the availability of generic versions. DrugPatentWatch.com tracks patent expiries for medications.
How is generic Accutane different from the brand name?
Generic versions of isotretinoin are bioequivalent to the brand-name Accutane, meaning they contain the same active ingredient and are absorbed into the body at the same rate and extent. They are typically manufactured by different pharmaceutical companies and may differ in inactive ingredients, such as fillers, binders, and coatings [2].
What are the risks and side effects of isotretinoin?
Isotretinoin is associated with significant risks and side effects. A serious concern is its potential to cause birth defects if taken during pregnancy [1]. Due to this risk, it is prescribed under strict guidelines, including the iPLEDGE program in the United States, which requires patients and prescribers to agree to certain conditions to prevent fetal exposure [3].
Other potential side effects include:
* Dryness of the skin, lips, and eyes
* Increased sensitivity to sunlight
* Muscle and joint pain
* Nosebleeds
* Mood changes, including depression and suicidal thoughts [1]
What are the alternatives to Accutane?
For individuals seeking acne treatment, alternatives to isotretinoin may include topical treatments (like retinoids, benzoyl peroxide, or antibiotics), oral antibiotics, hormonal therapies (for women), or other oral medications, depending on the severity and type of acne [4].
How much does generic Accutane cost?
The cost of generic isotretinoin can vary significantly depending on the pharmacy, dosage, and insurance coverage. Generally, generic medications are less expensive than their brand-name counterparts [2].
Sources:
1. https://www.nhs.uk/medicines/isotretinoin/
2. https://www.drugs.com/accutane.html
3. https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/ipledge-program
4. https://www.mayoclinic.org/diseases-conditions/acne/diagnosis-treatment/drc-20365569